EConsent Clinical Trials 2025: Process, Compliance, Benefits

The days of potential study participants flipping through dense stacks of paper are quickly ending. The informed consent process, a cornerstone of ethical research, is going digital. Electronic informed consent, or eConsent, is transforming how researchers communicate with participants. It is a critical component of modern research, especially for decentralized and hybrid studies.

But what exactly is eConsent? It is the use of digital tools like tablets, computers, and apps to present study information and document a participant’s voluntary agreement to join a trial. Instead of a static document, eConsent uses text, graphics, audio, and video, supported by patient engagement tools, to create a more engaging and understandable experience. This guide breaks down everything you need to know about implementing econsent clinical trials, from the core process and regulatory rules to the practical benefits for your study.

The eConsent Experience: A Patient Centered Pathway

The goal of eConsent is not to change what information is provided to a participant, but how it’s presented and captured. The process must follow the same legal and ethical standards as paper, ensuring participants receive clear information, have a chance to ask questions, and agree to join without pressure.

What the Patient Journey Looks Like

The electronic informed consent process is a flexible workflow that can happen at a research site or entirely remotely. For the participant, the pathway is clear and empowering.

1. Invitation: The participant receives a secure link via email or text message, or is handed a tablet at the clinic.
2. Information Review: They open the eConsent form on their device and review the study information, which is broken down into easy to navigate sections. They can move back and forth at their own pace.
3. Interaction: The participant engages with multimedia content, clicks on definitions for complex terms, and completes knowledge checks to confirm their understanding.
4. Questions: They have an opportunity to ask questions, often through a live video call with study staff or through a secure messaging portal.
5. Signature: Once all questions are answered and they agree to participate, they provide their electronic signature.
6. Confirmation: The participant immediately receives a signed digital copy of the consent form for their records.

More Than Just Text: Using Multimedia Components

Unlike paper, eConsent can incorporate multimedia to cater to different learning styles. Imagine watching a short animated video of a procedure instead of reading dense text about it. Research shows that when information includes color pictures or graphics, participants are 80% more willing to read it. Given the choice, about 80% of people would rather watch a video than read pages of text to learn about a study.

These multimedia components can include:

• Videos and animations to explain procedures.
• Interactive timelines to illustrate the schedule of study visits.
• Clickable glossaries for instant definitions of medical terms.
• Knowledge checks or quizzes to help participants confirm their understanding of key concepts.

Ensuring Broad Access and Usability

A successful eConsent process hinges on a positive user experience. The design should prioritize clarity and ease of use to ensure participants feel confident, not confused. This means using plain language and breaking down information into smaller chunks. Good design also includes intuitive navigation and compatibility across different devices, from smartphones to desktops.

However, a key challenge is addressing varied levels of digital literacy and access. To ensure technology does not become a barrier, a truly inclusive platform must:

• Support multiple devices, working seamlessly on a phone, tablet, or computer.
• Offer accessibility features, such as adjustable text sizes and screen reader compatibility for visually impaired users.
• Provide alternatives, such as in person guidance at a site or the option to use a traditional paper form for those unable or unwilling to use a digital device.

How eConsent Boosts Enrollment and Retention

One of the most significant impacts of eConsent is on participant enrollment and retention. By enabling a remote consent process, sponsors can reach a much wider and more diverse population that is not limited by geography. This is a critical advantage for studies targeting rare diseases or specific demographics, making econsent clinical trials more inclusive.

Furthermore, a better informed participant is often a more engaged participant. The clarity and interactivity of the eConsent process can set a positive tone for the entire study. When participants feel respected and fully understand what is expected of them, they are more likely to remain in the trial, reducing dropout rates and strengthening the integrity of the study data.

Where Consent Happens: Remote vs. In Person

eConsent technology supports flexibility in where and how the consent process takes place, breaking down geographical barriers that have long limited clinical trial access.

eConsent vs. Remote Consent: What’s the Difference?

It is important to clarify two commonly used terms.

• eConsent refers to the tool or system used. It is the use of an electronic platform to present information and capture a signature.
• Remote consent refers to the method or location. It means the participant and the study staff are not in the same physical place.

eConsent technology is what enables an effective remote consent process, but you can also have remote consent using paper forms (for example, mailing documents). Conversely, eConsent can be completed entirely in person at a study site.

The Rise of Decentralized and Hybrid Trial Consenting

Remote capabilities are the engine behind decentralized clinical trials (DCTs). For these types of econsent clinical trials, eConsent is a necessity. It allows sponsors to recruit and enroll participants from anywhere.

Many studies now use a hybrid trial model, which blends both approaches. A participant might review the eConsent at home and then discuss it with the site team over the phone. Platforms like Curebase’s decentralized trial platform are built to support these flexible workflows, enabling a single study to enroll participants from their homes, local clinics, or community pharmacies.

Meeting Global Regulatory and Security Standards

While the technology is innovative, the rules are strict. Any system used for econsent clinical trials must meet rigorous standards for security, validity, and data integrity set by regulatory bodies.

What is a Compliant Electronic Signature?

An electronic signature (eSignature) is the digital equivalent of a handwritten signature. In the U.S., the ESIGN Act confirms that electronic signatures have the same legal standing as wet ink signatures, as long as they meet certain criteria.

For FDA regulated trials, the key regulation is 21 CFR Part 11, which defines the requirements for electronic records and signatures to be considered trustworthy and equivalent to paper.

Decoding 21 CFR Part 11 Compliance

Meeting 21 CFR Part 11 requirements is non negotiable for any eConsent platform used in FDA regulated trials. Key components include:

• System Validation: Documented proof that the software works correctly.
• Access Control: Restricting system access to authorized individuals.
• Audit Trails: Secure, computer generated logs that record every action.
• Record Integrity: Ensuring that signed records are locked to prevent tampering.

The Importance of the Audit Trail

The audit trail records who did what, and when, for every action taken on an electronic consent record. This unalterable log provides a complete history, from when a participant first opened the form to when the investigator countersigned it.

Verifying Identity in a Digital World

A critical step, especially for remote consent, is identity verification. Common authentication methods include a username and password, two factor authentication (a one time code sent to a phone or email), knowledge based questions, or uploading a photo of a government issued ID.

Data Security, Privacy, and Global Compliance

Because eConsent involves collecting personal and health information, privacy and security are paramount. Systems must use encryption to protect data. If the study involves protected health information (PHI), the eConsent process must also comply with the Health Insurance Portability and Accountability Act (HIPAA).

For global econsent clinical trials, compliance must extend to international regulations like Europe’s General Data Protection Regulation (GDPR). Top tier eConsent platforms also adhere to security standards like ISO 27001, which provides a framework for information security management. This ensures that participant data is protected regardless of where the trial is conducted.

Expanding Consent for Modern Research Needs

Modern clinical trials often require consent for more than just the primary study procedures. eConsent platforms are uniquely equipped to handle these complex, multi part permissions in a clear and organized way.

Consent for Biospecimens and Future Research

Many studies collect biological specimens (like blood or tissue) for analysis. The eConsent process can include specific, distinct sections where participants can agree to this collection. It can also be used to obtain consent for their samples to be stored and used in future, unspecified research, which is a critical component for building biorepositories.

Authorizing Electronic Health Record Access

To get a complete picture of a participant’s health, researchers often need access to their electronic health records (EHR). An eConsent form can include a specific authorization for this purpose, allowing participants to grant permission for the study team to securely retrieve relevant medical data. This streamlines data collection and reduces the burden on both participants and site staff.

Handling Special Populations and Scenarios

Not all consent processes involve a single adult participant. The technology must be flexible enough to handle more complex situations.

Pediatric Considerations for eConsent

In pediatric research, consent involves obtaining parental permission and, for children old enough to understand, the child’s assent. An eConsent platform can manage this multi party process with a detailed form for the parent and a separate, child friendly assent form with simpler language and age appropriate multimedia.

Multi Signatory Workflows and Legally Authorized Representatives (LARs)

A multi signatory workflow is needed anytime more than one signature is required. This could include a parent, a witness, or a Legally Authorized Representative (LAR). An LAR is a person permitted to consent on behalf of an adult who is unable to consent for themselves. eConsent systems can route the form to each signer in the correct sequence.

From Selection to Inspection: A Practical Guide

Successfully implementing eConsent requires careful planning, from choosing the right platform to preparing for regulatory review.

System Selection and Validation

Choosing an eConsent platform involves looking beyond features. You need a system that is fully validated and compliant with 21 CFR Part 11. It’s also important to pick a solution that is easy to use for both site staff and participants. A platform that integrates eConsent with other eClinical tools (such as ePRO/eCOA) like the one offered by Curebase, can further streamline workflows.

The Role of the IRB in eConsent Review

The Institutional Review Board (IRB) reviews both the content of the consent form and the electronic presentation. The IRB must approve the entire electronic process before it can be used in a study. Your submission should include the complete content, a description of the participant’s experience, and documentation confirming the platform’s security and compliance.

Implementation, Training, and Support

Switching from paper to digital requires change management. Site staff, investigators, and even IRB members will need training on the new platform and workflows. A smooth transition depends on getting buy in from all stakeholders and providing robust support. This includes comprehensive training materials, accessible help desks, and clear documentation to guide users through the new process.

FDA Submission and Inspection Readiness

For trials regulated by the FDA, you must be ready for inspection. This means being able to produce all consent records on demand, including signed forms and audit trails. eConsent makes this easier, as all documents are centrally located with reporting and oversight dashboards. Approximately 80% of stakeholders said eConsent made audits easier.

The Lifecycle of an Electronic Consent Form

Once a participant signs, the eConsent document begins its life as a critical study record that must be managed, shared, and stored according to strict rules.

eConsent Documentation and Recordkeeping

The eConsent system must generate a complete, signed, and dated copy of the consent form for each participant. This record should be stored securely, in or synchronized with the study’s integrated EDC, in a way that prevents it from being lost or altered.

Providing Participants a Copy and Ongoing Access

Regulations require that every participant receive a copy of the consent form they signed. With eConsent, this is typically handled by emailing a PDF of the signed document or making it available for download through a secure participant portal.

Archiving and Retention for the Long Term

Clinical trial records, including consent forms, must be retained for many years after a study is complete. An eConsent system must have a robust process for archiving these electronic records in a secure, readable format.

The Big Picture: Why eConsent Matters

Adopting econsent clinical trials is about more than just reducing paper. From a quality perspective, eConsent virtually eliminates common documentation errors like missing signatures or outdated forms.

For efficiency, eConsent streamlines everything. It allows for instant distribution of new consent versions, speeds up enrollment by enabling remote consent, and reduces the administrative burden on site staff. Many sponsors using modern platforms like Curebase report faster enrollment and greater participant diversity. To see how compliant eConsent and integrated workflows come together, schedule a demo.

Frequently Asked Questions about eConsent Clinical Trials

1. What is the main advantage of using econsent in clinical trials?

The main advantage is improved participant comprehension. Using multimedia and interactive formats helps people better understand the study they are joining. This is followed closely by improved data quality and operational efficiency.

2. Is eConsent compliant with FDA regulations?

Yes, as long as the system used is compliant with 21 CFR Part 11. This regulation outlines the requirements for electronic records and signatures, including the need for validation, access controls, and secure audit trails.

3. How does eConsent work for participants who are not tech savvy?

Best practices require that participants have an alternative. If someone is unable or unwilling to use the electronic system, they should be offered a traditional paper consent form or in person assistance.

4. Can eConsent clinical trials be conducted globally?

Yes, econsent clinical trials are used globally. However, implementers must consider the specific regulations of each country, such as the GDPR in Europe, which has its own rules regarding data privacy and electronic signatures.

5. What is the difference between eConsent and an electronic signature?

An electronic signature is just one component of eConsent. eConsent refers to the entire electronic process of presenting information, answering questions, and documenting consent. The eSignature is the specific action used to legally record that consent.

6. How does the IRB review an eConsent?

The IRB reviews both the content (the text, risks, benefits, etc.) and the format (the user interface, videos, quizzes). They must approve the entire electronic experience to ensure it is clear, accurate, and protects participants.